论文部分内容阅读
新的安全的肾上腺素能受体阻滞剂Celiprolol,即3-[-3-乙酰基-4-[3-特丁胺基-2-羟丙氧基]-苯基-1,1-二乙基尿,具有不同寻常的活性模式,临床调查业已完成。本品用于91名患有轻、中度高血压的病人。根据需要每天滴注200~900mg,结果表明本品在控制高血压和缓解心绞痛方面与氨酰心安(atenolol)或心得安(propranolol)有同样疗效,且还能提高耐受性。Celiprolol是一个安全、耐受性好,作用广,每天一次剂量的抗
The new safe adrenergic receptor blocker, Celiprolol, is 3 - [- 3-acetyl-4- [3-tert-butylamino-2-hydroxypropoxy] -phenyl- Ethyl urine, with an unusual pattern of activity, has been completed in clinical investigations. This product is used in 91 patients with mild to moderate hypertension. A daily infusion of 200-900 mg, as needed, shows that the product has the same efficacy as atenolol or propranolol in controlling hypertension and relieving angina and also increases tolerance. Celiprolol is a safe, well tolerated, broad-based, one-dose-daily response